Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Kos and Barr sign agreements to settle Niaspan patent litigation

April 18, 2005

Priority review for SomatoKine

April 18, 2005

Response submitted to FDA for Glumetza NDA

April 18, 2005

Bioaccelerate Holdings and Symbollon enter agreement for IoGen

April 18, 2005

Japanese approval for Follistim

April 15, 2005

Recent patents disclose new therapeutic agents for diabetes

April 15, 2005

Enrollment completed in TRIUMPH study of eculizumab for PNH

April 15, 2005

Antidiabetic effects of cytogenin in streptozotocin-induced diabetes in mice

April 15, 2005

Ferring launches Menopur

April 14, 2005

Perlegen licenses PPAR agonist from Mitsubishi Pharma

April 14, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...